Phoenix Children's Hospital
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Phoenix Children's Hospital sits in the top decile of US sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count).
Phoenix Children's Hospital: 26 sponsored US clinical trials, 5 recruiting.
Phoenix Children's Hospital sponsors 26 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 16 completed. 8 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Thalassemia in Children, with 1 trials.
Top-decile sponsor footprint
Phoenix Children's Hospital ranks in the top decile of sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 20 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
26 total, page 1 of 1
Palliative Care Integration in Pediatric Oncology Phase 1 Clinical Trials
NCT07696065
A Clinical Trial of Soluble Fiber for Asthma
NCT06372249
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
NCT04040452
Ovarian Tissue Cryopreservation
NCT06710769
Modulation of Molecular Fingerprinting in Pediatric Sepsis
NCT02055105
Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair
NCT03730454
Oral Penicillin Challenge and Allergy De-labeling in Children
NCT05563610
Soluble Corn Fiber Supplementation for Asthma
NCT03673618
High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD
NCT03859336
Antibiotic Duration in Post-appendectomy Abscess
NCT03795194
Benefits of Exercise Program in Pediatric HSCT
NCT04663503
Evaluation of Implementation of the Phoenix PrEP (Pre-Exposure Prophylaxis) Access Project for Youth Aged 13-24
NCT03637322
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
NCT03176849
Benefits of Intrahospital Exercise Program in Pediatric HSCT
NCT06692478
Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis
NCT03289351
Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI
NCT03023566
Pain, Exercise and Psychological Well-being in Pectus Excavatum
NCT02337621
Using Near-infrared Spectroscopy (NIRS) Monitor to Noninvasively Evaluate Hepatic Venous Saturation
NCT01891188
Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment.
NCT01577810
Video-Based Social Learning or Didactics for Car Seat Education
NCT02720289
Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
NCT00940771
Validation of a Dehydration Scoring System
NCT00931177
Needle-Free Jet Injection of Lidocaine During Lumbar Puncture
NCT01224431
Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
NCT00762320
Hypothermia in Children After Trauma
NCT00222742
Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
NCT00585039
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 7 |
Where Phoenix Children's Hospital enrollment is open (later-stage tilt)
5 recruiting of 26 indexed (19% open); 16 completed (62%).
Phase mix: 8 late (III/IV) vs 3 early (I/II) (later-stage heavy).
Top condition: Thalassemia in Children (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Phoenix Children's Hospital: open-pipeline peers nationwide
Peers matched on 26 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Phoenix Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 26 trials (± recruiting share)
- Abbott Diabetes Care · 26 trials · 12% recruiting
- Aldeyra Therapeutics · 26 trials · 4% recruiting
- California Polytechnic State University-San Luis Obispo · 26 trials · 19% recruiting
- DexCom · 26 trials · 4% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
- Mayo Clinic · 19% recruiting · 2,844 trials
- University of South Carolina · 19% recruiting · 157 trials
- University of Texas Southwestern Medical Center · 19% recruiting · 837 trials
Related
What to do with this Phoenix Children's Hospital page
26 registered trials is a research-attention snapshot, not an endorsement of Phoenix Children's Hospital or any single study.
- 5 of Phoenix Children's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Thalassemia in Children is the condition Phoenix Children's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Thalassemia in Children trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Phoenix Children's Hospital pipeline card: 26 registered trials from official public datasets.Report a data error.